SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories reports Profit after tax of Rs 251.43 Mln, in the March 2021 quarter

04 May 2021 Evaluate
The Sales for the quarter ended March 2021 of Rs. 2641.05 millions rose by 39.63% from Rs. 1891.51 millions.The company almost doubled its revenue to Rs. 251.43 millions  from Rs. 94.78 millions in the quarter ended March 2021.Operating Profit saw a handsome growth to 315.20 millions from 180.69 millions in the quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 2641.05 1891.51 39.63 11124.22 7919.87 40.46 7919.87 7172.43 10.42
Other Income 38.68 17.22 124.62 117.73 94.17 25.02 94.17 36.72 156.45
PBIDT 315.20 180.69 74.44 1241.43 738.83 68.03 738.82 686.93 7.55
Interest -0.54 6.20 -108.71 17.88 19.67 -9.10 19.68 20.71 -4.97
PBDT 315.74 174.49 80.95 1223.55 719.16 70.14 719.14 666.22 7.94
Depreciation 64.31 79.71 -19.32 281.10 344.33 -18.36 344.34 380.08 -9.40
PBT 251.43 94.78 165.28 942.45 374.83 151.43 374.80 286.14 30.98
TAX 0.00 0.00 0.00 0.00 51.49 0.00 51.49 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 251.43 94.78 165.28 942.45 323.34 191.47 323.31 286.14 12.99
Equity 899.59 899.59 0.00 899.59 899.59 0.00 899.59 899.59 0.00
PBIDTM(%) 11.93 9.55 24.93 11.16 9.33 19.63 9.33 9.58 -2.60

Morepen Laboratories Share Price

41.35 -0.57 (-1.36%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×